GPR65 and supranuclear palsy, progressive, 1: In the FE group, there was a decreasing trend in GPR65 expression among patients with FE recurrence (Fig. 1G), while there was no statistically significant difference in terms of patient’s gender, PSP, etc. (Fig. 1H, I).